| ALEXION PHARMACEUTICALS INC | 136.98 / +3.71% |
| Date/Time | 04/16 / 17:32 |
| Chg. / Chg.(%) | 4.90 / +3.71% |
| Bid | - |
| Ask | - |
| Open | 131.38 |
| Previous Close | 132.08 |
| High | 136.98 |
| Low | 131.38 |
| Volume [EUR] | 20,574.40 |
| Volume [Units] | 154 |
| Price fixings | 7 |
| ISIN | US0153511094 |
| Security | ALXN |
| Exchange | Vienna Global Market |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 135.10 |  |
|
| NASDAQ | 163.6800 |  |
7,307,061 |
| Cboe US | 163.70 | |
498,140 |
| IEX | 163.66 | |
224,820 |
| London Inter.. | 164.20 | |
25,030 |
| TradeGate | 136.760 | |
656 |
| Frankfurt | 137.4400 | |
530 |
| Xetra | 137.04 | |
507 |
| gettex | 136.640 | |
294 |
| Vienna Globa.. | 136.98 | |
154 |
| Stuttgart | 136.680 | |
135 |
| Düsseldorf | 136.48 | |
50 |
| Berlin | 130.90 | |
0 |
| München | 131.20 | |
0 |
| Mexico | 3,140.98 | |
282 |
News
- Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
04/13/2021 / 14:00 - GlobeNewswire - Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
04/13/2021 / 12:30 - GlobeNewswire - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
04/09/2021 / 15:05 - GlobeNewswire - Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
04/09/2021 / 14:00 - GlobeNewswire - Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
04/08/2021 / 13:40 - GlobeNewswire
Real-time